Presentation of the NANEMIAR Project in the Region of Murcia for Congenital Anemias
Congenital anemias are genetic hematological diseases that affect the production or function of red blood cells. Although not widely known, they have a significant impact on the quality of life of those affected, especially during childhood and adolescence.
The NANEMIAR project was created with the goal of promoting early diagnosis, research, and the development of innovative therapies based on nanomedicine and genetics, combining the work of specialists in hematology, molecular biology, and nanotechnology.
The presentation was led by María Dolores Muñoz Navarro, a patient and researcher in the project, and María Dolores Navarro Marín, mother of the aforementioned patient, offering a more personal and family-oriented perspective. The event emphasized the importance of
bringing scientific innovation closer to the regional clinical setting, strengthening the capacity for detection and treatment in Murcian hospitals.
It also highlighted the Region of Murcia’s commitment to biomedical research, improved care for rare diseases, and the promotion of blood donation.
The advancement of the NANEMIAR project represents a decisive step toward a more personalized and humane medicine — one that seeks to improve the lives of patients with congenital anemias through knowledge, collaboration, and innovation.
You can watch the full interview here: